Moore AP

제1저자 또는 공저자로 매칭된 논문 · word-boundary on `authors` column

8 논문
2 최근 5년
2016–2022 활동기

주요 저널

  • The Cochrane database of systematic reviews 7
  • Movement disorders clinical practice 1

주요 공저자 Top 8

  1. Rodrigues FB 7편
  2. Duarte GS 7편
  3. Castelão M 7편
  4. Marques RE 7편
  5. Ferreira J 7편
  6. Sampaio C 7편
  7. Costa J 7편
  8. Chueluecha C 1편

연도별 분포

  • 2022 1
  • 2021 1
  • 2020 3
  • 2017 1
  • 2016 2

최근 발표

공저자 네트워크

중심 = Moore AP · 공저 횟수 상위 30
공저자 엣지
본인 공저자 본인-공저자 공저자 사이
⏳ 그래프 로딩 중…

노드 더블클릭 = 해당 저자 페이지로 이동 · 호버 = 공저 횟수 툴팁

논문 목록

8건 · 최신순
  • LIVECHART Patient-Reported Outcome Tool for Botulinum Toxin Treatment in Cervical Dystonia.
    Movement disorders clinical practice 2022 Chueluecha C 외 PMID: 35141354

    [BACKGROUND] Many tools used for recording the response to botulinum toxin treatment are disease-specific, observer-based and cumbersome to implement in service settings, especially where clinics treat a variety of disorders. Physicians, cl…

  • Botulinum toxin type A versus anticholinergics for cervical dystonia.
    The Cochrane database of systematic reviews 2021 Rodrigues FB 외 PMID: 33852744

    [BACKGROUND] This is an update of a Cochrane Review first published in 2005. Cervical dystonia is the most common form of focal dystonia and is a highly disabling movement disorder, characterised by involuntary, usually painful, head postur…

  • Botulinum toxin type A therapy for cervical dystonia.
    The Cochrane database of systematic reviews 2020 Rodrigues FB 외 PMID: 33180963

    [BACKGROUND] This is an update of a Cochrane Review first published in 2005. Cervical dystonia is the most common form of focal dystonia, and is a highly disabling movement disorder, characterised by involuntary, usually painful, head postu…

  • Botulinum toxin type A therapy for blepharospasm.
    The Cochrane database of systematic reviews 2020 Duarte GS 외 PMID: 33211907

    [BACKGROUND] This is an update of a Cochrane Review first published in 2005. Blepharospasm is the second most common form of focal dystonia. It is a disabling disorder, characterised by chronic, intermittent or persistent, involuntary eyeli…

  • Botulinum toxin type A therapy for hemifacial spasm.
    The Cochrane database of systematic reviews 2020 Duarte GS 외 PMID: 33211908

    [BACKGROUND] This is an update of a Cochrane Review, first published in 2005. Hemifacial spasm (HFS) is characterised by unilateral, involuntary contractions of the muscles innervated by the facial nerve. It is a chronic disorder, and spont…

  • Botulinum toxin type A therapy for cervical dystonia.
    The Cochrane database of systematic reviews 2017 Castelão M 외 PMID: 29230798

    [BACKGROUND] This is an update of a Cochrane Review first published in 2005. Cervical dystonia is the most common form of focal dystonia and is a highly disabling movement disorder characterised by involuntary, usually painful, head posturi…

  • Botulinum toxin type B for cervical dystonia.
    The Cochrane database of systematic reviews 2016 Marques RE 외 PMID: 27176573

    [BACKGROUND] This is an update of a Cochrane review first published in 2004, and previously updated in 2009 (no change in conclusions). Cervical dystonia is a frequent and disabling disorder characterised by painful involuntary head posturi…

  • Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
    The Cochrane database of systematic reviews 2016 Duarte GS 외 PMID: 27782297

    [BACKGROUND] This is an update of a Cochrane review first published in 2003. Cervical dystonia is the most common form of focal dystonia and is a disabling disorder characterised by painful involuntary head posturing. There are two availabl…